About the Authors

Tan N. Doan

Affiliation Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia

David C. M. Kong

emma.mcbryde@mh.org.au (ESM); david.kong@monash.edu (DCMK)

Affiliation Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia

Caroline Marshall

Affiliations Victorian Infectious Diseases Service, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia

Carl M. J. Kirkpatrick

Affiliation Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia

Emma S. McBryde

emma.mcbryde@mh.org.au (ESM); david.kong@monash.edu (DCMK)

Affiliations Victorian Infectious Diseases Service, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia

Competing Interests

DCMK has sat on advisory boards of Pfizer, Merck Sharp & Dohme, and receives financial/travel support (unrelated to the current work) from Pfizer, Roche, Merck Sharp & Dohme, Novartis and Gilead Sciences. CMJK has undertaken collaborative research projects unrelated to the current work with Roche, Pfizer, CSL and d3 Medicine. All other authors: none to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: TND DCMK CM CMJK ESM. Performed the experiments: TND ESM. Analyzed the data: TND ESM. Wrote the paper: TND DCMK CMJK ESM. Interpreted the study results: TND DCMK CM CMJK ESM.